---
created: '2026-02-09T05:54:32.194450Z'
description: Uncompetitive NMDA receptor antagonist. Protects neurons from excitotoxicity.
  Used for moderate to severe Alzheimer's disease.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/drug/memantine/
slug: memantine
tags:
- drug
- alzheimers
- neuroprotection
- nmda_antagonist
templateEngineOverride: njk
title: Memantine
type: drug
updated: '2026-02-09T05:54:32.194450Z'
---

{% raw %}
<h1>Memantine</h1>
<h2>Overview</h2>
<p>Memantine (Namenda) represents a distinct class of Alzheimer's treatment. Unlike cholinesterase inhibitors (which boost signal), Memantine reduces <strong>noise</strong> (excitotoxicity).</p>
<p>In Alzheimer's, damaged neurons release excessive <strong>Glutamate</strong>, which overstimulates NMDA receptors, leading to toxic Calcium influx and cell death. Memantine blocks this &quot;tonic&quot; overstimulation without interfering with the &quot;phasic&quot; signals required for learning.</p>
<h2>Indications</h2>
<ul>
<li><strong>Alzheimer's Disease</strong>: Moderate to Severe (often combined with Donepezil).</li>
<li><strong>Vascular Dementia</strong>: Off-label.</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>← [[Glutamate]] (neurotransmitter)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:35.159786'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.667638'
source: obsidian
</code></pre>
<ul>
<li>→ [[NMDA_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.667638'
source: obsidian
</code></pre>
<ul>
<li>→ [[NMDA_Receptor]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:42.400780'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:42.400780'
source: obsidian
</code></pre>
<ul>
<li>→ [[Glutamate]] (neurotransmitter)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:42.400780'
source: obsidian
</code></pre>
<ul>
<li>← [[Alzheimers_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:23.210589'
source: obsidian
</code></pre>
<ul>
<li>← [[Quetiapine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:00.766849'
source: obsidian
</code></pre>
<ul>
<li>→ [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.667638'
source: obsidian
</code></pre>
<ul>
<li>→ [[Quetiapine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.667638'
source: obsidian
</code></pre>
<ul>
<li>← [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:59.154865'
source: obsidian
</code></pre>
<h3>Interactswith</h3>
<ul>
<li>→ [[Quetiapine]] (drug)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:37.681000+00:00'
source: PrimeKG
</code></pre>
<ul>
<li>→ [[Imipramine]] (drug)</li>
</ul>
<pre><code class="language-yaml">imported: '2025-12-26T11:56:37.022000+00:00'
source: PrimeKG
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Modulates Neurotransmitter</h3>
<ul>
<li>⊣ [[Glutamate]] (neurotransmitter) - <em>Blocks toxicity</em></li>
</ul>
<h3>Modulates Protein</h3>
<ul>
<li>⊣ [[NMDA Receptor]] (protein) - <em>Uncompetitive Antagonist</em></li>
</ul>
<h3>Treats Condition</h3>
<ul>
<li>→ [[Alzheimer's Disease]] (condition) - <em>Moderate-Severe</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Mechanism</strong>: Lipton, S. A. (2006). &quot;Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.&quot; <em>Nature Reviews Drug Discovery</em>.</li>
</ol>

{% endraw %}